NCT00002354View on ClinicalTrials.gov

A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

NACompletedINTERVENTIONAL

Enrollment

540

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Indinavir sulfate

DRUG

Stavudine

Trial Locations (1)

088890100

Merck & Co Inc, Whitehouse Station

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00002354 - A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients | Biotech Hunter | Biotech Hunter